Support Our Research

The Levicure team shares their human oral combination therapy results, showing increases in c-peptide in newer T1Ds and reduced insulin demand on older T1Ds.

Levciure presentation on The (Sugar) Science in 2022. Dr. Levit and the team at Levicure share their research on oral combination therapy for T1D remission and reduced insulin demands.